1.
Chinese Pharmacological Bulletin
;
(12)1986.
Artigo
em Chinês
| WPRIM
| ID: wpr-559212
RESUMO
Aim To investigate the effects of the novel compound C333H on reduce blood glucose and lipid in vivo.Methods Normal KM mice,hyperlipidaemia mice and type 2 diabetic mice by intragastric gavage were used and total RNA from liver,adipose and skeletal muscle were isolated for RT-PCR.Results C333H reduced blood lipid level and improved glucose metabolism.In addition,C333H increased expressions of LPL,aP2 and GluT4 at transcriptional level.Conclusion C333H is a novel PPAR?/? agonist,signivicantly reducing blood lipid and glucose,which had potential as a therapy for type 2 diabetes.